Drug Trial Radar · NCT07718685
Comparative Study of Topical Oxiconazole 1% Cream Versus Clotrimazole 1% Cream in the Treatment of Dermatophytosis
Last checked: Nov 19, 2026Latest source record: Jul 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
164
Actual
Start
Jan 1, 2025
Primary completion
Jun 30, 2025
Study completion Jun 30, 2025
Sponsor
- Lead sponsor
- Shalamar Institute of Health SciencesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 22, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To compare the efficacy of oxiconazole 1 % cream and clotrimazole cream for treatment of dermatophytosis
Conditions
- Dermatophytoses
Interventions
Oxiconazole Nitrate CreamDrug
Oxiconazole 1 % cream will be applied on dermatophytosis lesions
Clotrimazole CreamDrug
Clotrimazole cream will be applied to clotrimazole group on dermatophytosis lesions
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy in terms of clearance of lesions , pruritis and scalingTime frame: 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Shalamar hospital
Lahore, Punjanb, Pakistan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.